Michael J Joyner Selected Research

Dopamine (Intropin)

1/2020	Role of the carotid chemoreceptors in insulin-mediated sympathoexcitation in humans.
1/2018	Effects of intravenous low-dose dopamine infusion on glucose regulation during prolonged aerobic exercise.
7/2016	Reductions in carotid chemoreceptor activity with low-dose dopamine improves baroreflex control of heart rate during hypoxia in humans.
1/2016	Interindividual variability in the dose-specific effect of dopamine on carotid chemoreceptor sensitivity to hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Joyner Research Topics

Disease

32	COVID-19 04/2024 - 01/2020
27	Hypoxia (Hypoxemia) 01/2023 - 06/2003
15	Hyperemia 01/2019 - 12/2003
14	Hypertension (High Blood Pressure) 01/2021 - 10/2004
9	Heart Failure 12/2020 - 10/2002
8	Infections 04/2024 - 01/2021
8	Hyperoxia 01/2020 - 11/2010
7	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 08/2012
6	Hemorrhage 05/2024 - 01/2019
5	Hypovolemia 01/2024 - 11/2015
5	Communicable Diseases (Infectious Diseases) 11/2023 - 12/2020
5	Insulin Resistance 01/2017 - 11/2008
4	Obesity 11/2014 - 10/2004
3	Shock 05/2024 - 02/2016
3	Critical Illness (Critically Ill) 01/2021 - 08/2020
3	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 06/2014
3	Apnea 10/2019 - 04/2009
2	Hemoglobinopathies 01/2021 - 12/2019
2	Pain (Aches) 01/2021 - 06/2012
2	Autonomic Nervous System Diseases (Dysautonomia) 01/2020 - 01/2020
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2017 - 06/2014
2	Inflammation (Inflammations) 01/2017 - 07/2014
2	Hyperglycemia 01/2017 - 03/2004
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014 - 01/2014
2	Hypoglycemia (Reactive Hypoglycemia) 01/2014 - 01/2012
2	Hypercapnia 05/2013 - 06/2012
2	Type 2 Diabetes Mellitus (MODY) 11/2007 - 03/2006
2	Cystic Fibrosis (Mucoviscidosis) 06/2007 - 11/2005
2	Fatigue 11/2005 - 02/2004
1	Human Influenza (Influenza) 05/2024
1	Disease Progression 04/2024
1	Polycythemia (Erythrocytosis) 01/2023
1	Breakthrough Infections 05/2022
1	Lung Diseases (Lung Disease) 12/2021

Drug/Important Bio-Agent (IBA)

18	Oxygen (Dioxygen)IBA 01/2022 - 03/2006
14	Vasodilator Agents (Vasodilators)IBA 01/2019 - 03/2004
12	VaccinesIBA 04/2024 - 01/2020
9	AntibodiesIBA 01/2023 - 10/2020
9	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2004
7	Monoclonal AntibodiesIBA 04/2024 - 01/2021
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 05/2006
6	Hemoglobins (Hemoglobin)IBA 01/2023 - 12/2019
6	Vasoconstrictor AgentsIBA 01/2013 - 06/2003
5	Neutralizing AntibodiesIBA 01/2023 - 01/2021
5	Immunoglobulin G (IgG)IBA 01/2022 - 10/2020
5	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020 - 11/2005
5	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 12/2003
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2015 - 06/2003
5	Adrenergic Agents (Adrenergic Drugs)IBA 06/2014 - 06/2003
5	Insulin (Novolin)FDA Link 06/2014 - 03/2006
4	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2016
4	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2019 - 08/2006
4	Epinephrine (Adrenaline)FDA LinkGeneric 01/2015 - 11/2006
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2014 - 06/2012
3	Fentanyl (Sublimaze)FDA LinkGeneric 12/2020 - 12/2015
3	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 02/2017 - 05/2002
3	Adenosine Triphosphate (ATP)IBA 01/2016 - 11/2005
3	Hypoglycemic Agents (Hypoglycemics)IBA 08/2015 - 01/2012
3	Indomethacin (Indometacin)FDA LinkGeneric 05/2013 - 05/2009
3	Hormones (Hormone)IBA 03/2013 - 11/2010
3	TyramineIBA 01/2013 - 06/2003
2	COVID-19 VaccinesIBA 04/2024 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2023 - 12/2019
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2022 - 08/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022 - 08/2022
2	Phenobarbital (Luminal)FDA Link 10/2022 - 08/2020
2	GasesIBA 01/2021 - 01/2020
2	voxelotorIBA 01/2021 - 01/2020
2	N 30IBA 01/2020 - 11/2005
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2017 - 02/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2017 - 05/2002
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2015 - 11/2010
2	Growth Hormone (Somatotropin)IBA 01/2015 - 11/2010
2	Glucagon (Glukagon)FDA Link 01/2015 - 11/2010
2	Fish OilsIBA 04/2013 - 08/2012
2	Dihydrotachysterol (AT 10)IBA 03/2011 - 11/2006
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 12/2003 - 05/2002
1	remdesivirIBA 02/2024
1	Therapeutic UsesIBA 01/2023
1	CoagulantsIBA 12/2022
1	Protein CIBA 12/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2022
1	AntigensIBA 12/2022

Therapy/Procedure

24	Therapeutics 04/2024 - 10/2002
10	Lower Body Negative Pressure 05/2024 - 11/2015
3	Aftercare (After-Treatment) 01/2021 - 01/2021
2	Mechanical Ventilators (Ventilator) 01/2021 - 01/2021
2	Transplantation 01/2021 - 08/2011
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 08/2020
2	Sympathectomy (Sympathectomies) 01/2021 - 05/2002
2	Precision Medicine 12/2019 - 05/2016
2	Intra-Arterial Infusions 02/2017 - 08/2006
2	Denervation 01/2016 - 12/2013
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2013 - 04/2011
2	Erythrocyte Transfusion 06/2012 - 05/2010
1	Immunotherapy 05/2024
1	Wearable Electronic Devices 01/2023
1	Biological Therapy 01/2022